Viridian Therapeutics, Inc. · NASDAQ:VRDN
Tousignant Jennifer sold 14,212 Viridian Therapeutics, Inc. shares (Form 4)
Traded Aug 19, 2026 · Filed Aug 20, 2026
On Aug 19, 2026, Tousignant Jennifer (Chief Legal Officer) sold 14,212 Viridian Therapeutics, Inc. shares at US$24.50 for US$348K, leaving 0 shares. Filed Aug 20, 2026 (Form 4).
- Sold
- 14,212 shares
- Price
- US$24.50
- Value
- US$348K
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Common Stock | Sale | 4,212 | US$24.50 | 0 | Direct |
| Aug 19, 2026 | Common Stock | Option exercise | 10,000 | US$14.41 | 10,000 | Direct |
| Aug 19, 2026 | Common Stock | Sale | 10,000 | US$24.50 | 0 | Direct |
Source
Related
- Viridian Therapeutics, Inc.
- Tousignant Jennifer
- Viridian Therapeutics, Inc. shareholders
- Schedule 13G · Point72 Asset Management, L.P. · Aug 20, 2026
- Form 4 · Tripuraneni Radhika · Aug 18, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Paradigm Biocapital Advisors LP · Aug 14, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026